Aragen Bioscience

Aragen Bioscience, Innovent Biologics collaborate on biotherapeutic product development

Wednesday, April 3, 2013

Aragen Bioscience, a privately held CRO, and Innovent Biologics, a privately held biopharmaceutical company, have initiated a collaboration for the development of manufacturing cell lines for biotherapeutic product development. Aragen Bioscience will develop robust CHO cell lines and assess critical product quality attributes for various antibodies and protein therapeutics. 

[Read More]